| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 28 Jun 2024 | 24 Jun 2024 |
| Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/06/2024 inter alia to consider and approve This is to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Friday June 28th 2024 to consider the following items: a) Sub-division/split of existing 1 (One) Equity Share of the face value of Rs. 10/- (Rupees Ten Only) each fully paid up into 5 (Five) Equity Shares of the face value of Rs. 2/- (Rupees Two Only) each fully paid up. b) Reclassification of the persons from the Promoter Group Category to the Public Category. The Board approved Re-classification of persons falling under Promoter Group and Sub-division/Stock Split of equity shares of the Company Approval of Board of Directors for Re-classification of Promoter Group to Public Category. (As Per BSE Announcement Dated on: 28/06/2024) | ||
| Board Meeting | 16 May 2024 | 2 May 2024 |
| Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 inter alia to consider and approve the audited (Standalone & Consolidated) financial results of the company for the quarter and financial year ended March 31 2024. Results- Financial Results for the FY ended 31.3.2024 Re- appointment of Statutory Auditors (As per BSE Announcement Dated on 16/05/2024) | ||
| Board Meeting | 3 Feb 2024 | 23 Jan 2024 |
| Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2024 inter alia to consider and approve the un-audited (Standalone & Consolidated) financial results of the company for the quarter and nine months ended December 31 2023. Outcome of Board Meeting held on 3rd February, 2024 (As Per BSE Announcement Dated on: 03/02/2024) | ||
| Board Meeting | 28 Nov 2023 | 28 Nov 2023 |
| Outcome of Board Meeting held on 28th November 2023 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Intimation of Change of Directors pursuant to Regulation 30 of SEBI LODR. | ||
| Board Meeting | 7 Nov 2023 | 30 Oct 2023 |
| Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2023 inter alia to consider and approve the un-audited (Standalone & Consolidated) financial results of the company for the quarter and half-year ended September 30 2023. Approval of unaudited Quarterly and financial results for the quarter and half yearly ended 30.09.2023. unaudited financial results for the quarter and Half Yearly ended 30.09.2023 Resignation of Mr. Shantanu Rastogi as Non-Executive & Non-Independent Director of the Company. (As Per BSE Announcement dated on 07.11.2023) | ||
| Board Meeting | 7 Aug 2023 | 31 Jul 2023 |
| Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 inter alia to consider and approve meeting of the Board of Directors of Krishna Institute of Medical Sciences Limited is scheduled to be held on Monday August 7 2023 inter alia to consider and approve the Unaudited (Standalone & Consolidated) Financial results of the company for the 1st quarter ended June 30 2023. Further to our intimations dated 31st July 2023, the Board of Directors, at its meeting held today, has approved the Un-Audited (Standalone and Consolidated) Financial Results of the Company for the 01st Quarter ended 30th June 2023 together with Limited Review Reports which has been reviewed by the Audit Committee and approved by the Board of Directors. Dr. B. Bhaskara Rao, Promoter & CMD has intimated to the Board that he has acquired 64.36% of the equity stake in M/s. Som Datt Finance Corporation Ltd, (Listed NBFC) and has been inducted into its Board as a Director. 1. Approval of unaudited financial Results for the Quarter ended 30.06.2023. 2. Dr. B Bhaskara Rao has intimated the Board that he has acquired 64.36% of Equity stake in Som Datt Finance Corporation Limited and has been inducted into its Board as Director. (As per BSE Announcement Dated on 07/08/2023) | ||
| Board Meeting | 26 Jul 2023 | 26 Jul 2023 |
| Intimation of the Appointment of Mr. Sachin Ashok Salvi as Chief Financial Officer and KMP of the Company w.e.f August 01, 2023 | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
